performance-enhancing drugs

3Qs: Downhill course for Lance Armstrong

Dan Lebowitz, the executive director of Sport in Society, examines the decision by the United States Anti-Doping Agency to strip cyclist Lance Armstrong of his Tour de France victories.
- by Matt Collette August 28, 2012
3Qs: Sports under a microscope of suspicion

The winner of the 98th Tour de France will be crowned on Sunday in Paris. But the event has been tainted by ongoing allegations of blood doping and the use of performance-enhancing drugs by cycling’s top performers. We asked Dan Lebowitz, executive director of Sport in Society, a Northeastern University research center, to analyze the impact of such illegal practices in professional sports.
- by Jason Kornwitz July 21, 2011

X

Cookies on Northeastern sites

This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.